ScholarIQanswers from OpenAlex
Moores Cancer Center
InstitutionResearch output, impact & collaborations
Moores Cancer Center is a institution indexed in ScholarIQ from OpenAlex.
What is known about Moores Cancer Center?
ScholarIQrecord summary
Moores Cancer Center is a research organisation in La Jolla. OpenAlex records 3,210 works and 488,391 citations for it. 438 researchers list it as their most recent affiliation.
How many works does Moores Cancer Center have?
ScholarIQindexed works
Moores Cancer Center has 3,210 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Moores Cancer Center have?
ScholarIQcitation count
Moores Cancer Center has 488,391 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Moores Cancer Center?
ScholarIQresearcher count
Moores Cancer Center has 438 researchers in the ScholarIQ index.
What is the average h-index at Moores Cancer Center?
ScholarIQavg h-index
Moores Cancer Center has an average h-index of 85 in OpenAlex.
What is the ROR of Moores Cancer Center?
ScholarIQror
The ROR for Moores Cancer Center is on the source record.
What is the OpenAlex record for Moores Cancer Center?
ScholarIQopenalex
The OpenAlex for Moores Cancer Center is on the source record.
Who are the most-cited researchers behind Moores Cancer Center?
ScholarIQtop researchers by citations
What are the most-cited papers on Moores Cancer Center?
ScholarIQmost cited works
Positive Surgical Margins in the 10 Most Common Solid Cancers
Ryan K. Orosco, Viridiana J. Tapia, Joseph A. Califano, Bryan M. Clary, Ezra E.W. Cohen, Christopher Kane, Scott M. Lippman, Karen Messer, Alfredo Molinolo, James D. Murphy, John Pang, Assuntina G. Sacco, Kathryn R. Tringale, Anne M. Wallace, Quyen T. Nguyen
Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands
Mark Agulnik, Ezra E.W. Cohen, Roger B. Cohen, Eric X. Chen, Everett E. Vokes, Sebastién J. Hotte, Eric Winquist, Scott A. Laurie, D. Neil Hayes, Janet Dancey, Shirley Brown, Gregory R. Pond, Ian Lorimer, Manijeh Daneshmand, Jcm Ho, Ming‐Sound Tsao, Lillian L. Siu
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
Assuntina G. Sacco, Ruifeng Chen, Francis P. Worden, Deborah Jean Lee Wong, Douglas R. Adkins, Paul Swiecicki, Wanxing Chai‐Ho, Peter Oppelt, Debanjali Ghosh, Julie Bykowski, Alfredo Molinolo, Emily Pittman, Mónica V. Estrada, Kathryn A. Gold, Gregory A. Daniels, Scott M. Lippman, Amanda Natsuhara, Karen Messer, Ezra E.W. Cohen
Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity
Mark W. Lingen, Elliot Abt, Nishant Agrawal, Anil K. Chaturvedi, Ezra E.W. Cohen, Gypsyamber DʼSouza, JoAnn Gurenlian, John R. Kalmar, Alexander Ross Kerr, Paul M. Lambert, Lauren L. Patton, Thomas P. Sollecito, Edmond L. Truelove, Malavika P. Tampi, Olivia Urquhart, Laura Banfield, Alonso Carrasco‐Labra
Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis
Christos Perisanidis, Amanda Psyrri, Ezra E.W. Cohen, Johannes Engelmann, Georg Heinze, Beata Perisanidis, Anton Stift, Martin Filipits, Gabriela Kornek, Emeka Nkenke
How much of the research on Moores Cancer Center is open access?
ScholarIQopen access share
67%OPEN ACCESS